adenosine monophosphate has been researched along with Age-Related Macular Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J; Sun, Z; Xu, G; Zhuang, X | 1 |
| Cherepanova, GI; Smoliakova, GP | 1 |
| Rodivoz, MI; Smoliakova, GP | 1 |
3 other study(ies) available for adenosine monophosphate and Age-Related Macular Degeneration
| Article | Year |
|---|---|
SHP-1 knockdown suppresses mitochondrial biogenesis and aggravates mitochondria-dependent apoptosis induced by all trans retinal through the STING/AMPK pathways.
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Annexin A5; Apoptosis; Humans; Interferons; Macular Degeneration; Mitochondria; Organelle Biogenesis; Oxidative Stress; Phosphoric Monoester Hydrolases; Reactive Oxygen Species; Retinal Pigment Epithelium; Retinaldehyde | 2022 |
[Phosphaden in the treatment of patients with age-related macular dystrophies].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Adult; Aged; Aging; Drug Evaluation; Humans; Macular Degeneration; Middle Aged; Vision, Ocular | 1984 |
[Evaluation of the therapeutic action of DOPA and phosphaden in experimental dystrophic changes of the retina induced by disorders of the functional state of the sympatho-adrenal system].
Topics: Adenosine Monophosphate; Adrenal Medulla; Animals; Dihydroxyphenylalanine; Drug Evaluation, Preclinical; Macular Degeneration; Rabbits; Sympathetic Nervous System | 1988 |